Annals of Clinical Nutrition and Metabolism : eISSN 2799-8363 / pISSN 2799-7898

Table. 3.

Table. 3.

Relevance between risk of RS and severity of RS based on both ASPEN and NICE guidelines (between each group)

Risk Refeeding syndrome P-value

None (n=9) Mild RS (n=16) Moderate (n=15) Severe (n=46)
ASPEN guidelines 0.211
Without RS risk 1 (3.3) 7 (23.3) 4 (13.3) 18 (60.0)
Moderate Risk 8 (19.5) 5 (12.2) 8 (19.5) 20 (48.8)
Significant Risk 0 (0) 4 (26.7) 3 (20.0) 8 (53.3)
NICE guidelines 0.842
Without RS risk 1 (8.3) 3 (25.0) 1 (8.3) 7 (58.3)
With RS risk 8 (10.8) 13 (17.6) 14 (18.9) 39 (52.7)

Values are presented as number (%).

RS = refeeding syndrome; ASPEN = American Society for Parenteral and Enteral Nutrition; NICE = National Institute for Clinical Excellence.

Ann Clin Nutr Metab 2022;14:72-80 https://doi.org/10.15747/ACNM.2022.14.2.72
© 2022 Ann Clin Nutr Metab